Effects of oral amino acid supplements on functional capacity in patients with chronic heart failure

Clinical Medicine Insights: Cardiology

Volumn 8, Issue , 2014, Pages 39-44

  Lombardi, Carlo ^a   Carubelli, Valentina ^a   Lazzarini, Valentina ^a   Vizzardi, Enrico ^a   Quinzani, Filippo ^a   Guidetti, Federica ^a   Rovetta, Riccardo ^a   Nodari, Savina ^a   Gheorghiade, Mihai ^a   Metra, Marco ^a  

^a University and Civil Hospital of Brescia   (Italy)

Author keywords

Amino acid; Exercise capacity; Heart failure; Nutrition; Systolic dysfunction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMINOTROFIC; ESSENTIAL AMINO ACID; UNCLASSIFIED DRUG;

ADULT; ANAEROBIC THRESHOLD; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG EFFECT; DRUG SAFETY; DRUG TOLERANCE; EXERCISE TOLERANCE; FEMALE; FUNCTION TEST; FUNCTIONAL STATUS; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MALE; NEW YORK HEART ASSOCIATION CLASS; OXYGEN CONSUMPTION; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUESTIONNAIRE; SIX MINUTE WALKING TEST; SUPPLEMENTATION; TREATMENT DURATION; WALKING;

EID: 84901468400     PISSN: None     EISSN: 11795468     Source Type: Journal    
DOI: 10.4137/CMC.S14016     Document Type: Article

References (21)

1. Cleland JG, Swedberg K, Follath F, etal. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442-63.
2. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 2002;39:60-9.
3. Rosamond W, Flegal K, Furie K, etal. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-146.
4. Hunt SA, Abraham WT, Chin MH, etal. Focused update incorporated into the ACC/AHA 2005guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;53:e1-90.
5. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008;52:428-34.
6. Ahmed A, Allman RM, Fonarow GC, etal. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail. 2008;14:211-8.
7. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557-73.
8. Milo-Cotter O, Cotter-Davison B, Lombardi C, Sun H, Bettari L, et al. Neurohormonal activation in acute heart failure: results from VERITAS. Cardiology. 2011;119(2):96-105.
9. Taegtmeyer H, Harinstein ME, Gheorghiade M. More than bricks and mortar: comments on protein and amino acid metabolism in the heart. Am J Cardiol. 2008;101:3E-7E.
10. Lang RM, Bierig M, Devereux RB, etal. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
11. Januzzi JL Jr, Rehman SU, Mohammed AA, etal. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol. 2011;58(18):1881-9.
12. Ardehali H, Sabbah HN, Burke MA, etal. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail. 2012;14(2):120-9.
13. von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res. 2007;73:298-309.
14. Soukoulis V, Dihu JB, Sole M, et al. Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol. October 27, 2009;54(18):1660-73.
15. Azuma J, Hasegawa H, Sawamura A, etal. Therapy of congestive heart failure with orally administered taurine. Clin Ther. 1983;5:398-408.
16. Azuma J, Sawamura A, Awata N, etal. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol. 1985;8:276-82.
17. Mancini M, Rengo F, Lingetti M, Sorrentino GP, Nolfe G. Controlled study on the therapeutic efficacy of propionyl-l-carnitine in patients with congestive heart failure. Arzneimittelforschung. 1992;42:1101-4.
18. Anand I, Chandrashekhan Y, De Giuli F, etal. Acute and chronic effects of propionyl-l-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure. Cardiovasc Drugs Ther. 1998;12:291-9.
19. Aquilani R, Opasich C, Gualco A, etal. Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure. Eur J Heart Fail. 2008;10(11):1127-35.
20. Aquilani R, Viglio S, Iadarola P, etal. Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure. Am J Cardiol. 2008;101(suppl):104E-10E.
21. Scognamiglio R, Testa A, Aquilani R, Dioguardi FS, Pasini E. Impairment in walking capacity and myocardial function in the elderly: is there a role for nonpharmacologic therapy with nutritional amino acid supplements? Am J Cardiol. 2008;101(suppl):78E-81E.